Refractory Chylothorax and Ventricular Hypertrophy Treated with Trametinib in a Patient with Noonan Syndrome: 18-Month Follow-Up
RASopathies are a group of genetic syndromes caused by germline mutations in genes involved in the RAS/Mitogen-Activated Protein Kinase signaling pathway, which regulates cellular proliferation, differentiation, and angiogenesis. Despite their involvement at different levels of this pathway, RASopat...
Saved in:
Main Authors: | Antonia Pascarella (Author), Giuseppe Limongelli (Author), Alessandro De Falco (Author), Elia Marco Paolo Minale (Author), Giangiacomo Di Nardo (Author), Giovanni Maria Di Marco (Author), Geremia Zito Marinosci (Author), Giorgia Olimpico (Author), Paolo Siani (Author), Daniele De Brasi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thoracic Empyema Secondary to Congenital Chylothorax in a 14-Month-Old Boy with Noonan Syndrome
by: Takeru Oikawa, et al.
Published: (2021) -
Life-Threatening Obstructive Sleep Apnea Caused by Adenoid Hypertrophy in an Infant with Noonan Syndrome
by: Sonia Khirani, et al.
Published: (2012) -
Appropriateness of hospitalization for CAP-affected pediatric patients: report from a Southern Italy General Hospital
by: Antonelli Fabio, et al.
Published: (2009) -
Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib
by: Marco Caruana, MD, et al.
Published: (2020) -
Noonan Syndrome
by: Dina D., et al.
Published: (2018)